Synthetic biologics provide a path to target bHLH transcription factors
Crossref DOI link: https://doi.org/10.1038/s41587-022-01509-6
Published Online: 2022-11-03
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (DP2GM128199-01)
American Cancer Society (RSG-17-150-01-CDD)
Text and Data Mining valid from 2022-11-03
Version of Record valid from 2022-11-03
Article History
First Online: 3 November 2022